A fine-tuned interaction between trimeric autotransporter haemophilus surface fibrils and vitronectin leads to serum resistance and adherence to respiratory epithelial cells

Infection and Immunity

Volumn 82, Issue 6, 2014, Pages 2378-2389

  Singh, Birendra ^a   Su, Yu Ching ^a   Al Jubair, Tamim ^a   Mukherjee, Oindrilla ^a   Hallström, Teresia ^b   Mörgelin, Matthias ^c   Blom, Anna M ^a   Riesbeck, Kristian ^a  

^a LUND UNIVERSITY   (Sweden)

^b HANS KNÖLL INSTITUTE   (Germany)

^c LUND UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ADHESIN; BACTERIAL PROTEIN; COMPLEMENT MEMBRANE ATTACK COMPLEX; HAEMOPHILUS SURFACE FIBRIL; UNCLASSIFIED DRUG; VITRONECTIN; HEPARIN; HSF PROTEIN, BACTERIA;

AMINO TERMINAL SEQUENCE; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL VIRULENCE; BACTERIUM ADHERENCE; BACTERIUM MUTANT; BINDING SITE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; EPITHELIUM CELL; ESCHERICHIA COLI; HAEMOPHILUS INFLUENZAE TYPE B; IMMUNE EVASION; INTERNALIZATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; RESPIRATORY EPITHELIUM; ANALYSIS OF VARIANCE; BINDING COMPETITION; CELL ADHESION; DOSE RESPONSE; HUMAN; IMMUNOLOGY; METABOLISM; MICROBIOLOGY; PATHOGENICITY; PHYSIOLOGY; SERUM; SERUM BACTERICIDAL ACTIVITY;

ADHESINS, BACTERIAL; ANALYSIS OF VARIANCE; BINDING, COMPETITIVE; BLOOD BACTERICIDAL ACTIVITY; CELL ADHESION; COMPLEMENT MEMBRANE ATTACK COMPLEX; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; HAEMOPHILUS INFLUENZAE TYPE B; HEPARIN; HUMANS; SERUM; VITRONECTIN;

EID: 84900418637     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.01636-13     Document Type: Article

References (31)

1. Morris SK, Moss WJ, Halsey N. 2008. Haemophilus influenzae type b conjugate vaccine use and effectiveness. Lancet Infect. Dis. 8:435-443. http://dx.doi.org/10.1016/S1473-3099(08)70152-X.
2. Agrawal A, Murphy TF. 2011. Haemophilus influenzae infections in the H. influenzae type b conjugate vaccine era. J. Clin. Microbiol. 49:3728-3732. http://dx.doi.org/10.1128/JCM.05476-11.
3. Danovaro-Holliday MC, Garcia S, de Quadros C, Tambini G, Andrus JK. 2008. Progress in vaccination against Haemophilus influenzae type b in the Americas. PLoS Med. 5:e87. http://dx.doi.org/10.1371/journal.pmed.0050087.
4. Fitzwater SP, Watt JP, Levine OS, Santosham M. 2010. Haemophilus influenzae type b conjugate vaccines: considerations for vaccination schedules and implications for developing countries. Hum. Vaccin. 6:810-818. http://dx.doi.org/10.4161/hv.6.10.13017.
5. Ulanova M, Tsang RS. 2009. Invasive Haemophilus influenzae disease: changing epidemiology and host-parasite interactions in the 21st century. Infect. Genet. Evol. 9:594-605. http://dx.doi.org/10.1016/j.meegid.2009.03.001.
6. St. Geme JW, III. 1996. Molecular determinants of the interaction between Haemophilus influenzae and human cells. Am. J. Respir. Crit. Care Med. 154:S192-S196. http://dx.doi.org/10.1164/ajrccm/154.4_Pt_2.S192.
7. St. Geme JW, III, Cutter D. 1996. Influence of pili, fibrils, and capsule on in vitro adherence by Haemophilus influenzae type b. Mol. Microbiol. 21:21-31. http://dx.doi.org/10.1046/j.1365-2958.1996.6241331.x.
8. Singh B, Fleury C, Jalalvand F, Riesbeck K. 2012. Human pathogens utilize host extracellular matrix proteins laminin and collagen for adhesion and invasion of the host. FEMS Microbiol. Rev. 36:1122-1180. http://dx.doi.org/10.1111/j.1574-6976.2012.00340.x.
9. Cotter SE, Yeo HJ, Juehne T, St. Geme JW, III. 2005. Architecture and adhesive activity of the Haemophilus influenzae Hsf adhesin. J. Bacteriol. 187:4656-4664. http://dx.doi.org/10.1128/JB.187.13.4656-4664.2005.
10. St. Geme JW, III, Kumar VV, Cutter D, Barenkamp SJ. 1998. Prevalence and distribution of thehmwand hia genes and theHMWand Hia adhesins among genetically diverse strains of nontypeable Haemophilus influenzae. Infect. Immun. 66:364-368.
11. St. Geme JW, III, Cutter D, Barenkamp SJ. 1996. Characterization of the genetic locus encoding Haemophilus influenzae type b surface fibrils. J. Bacteriol. 178:6281-6287.
12. Watson ME, Jr, Nelson KL, Nguyen V, Burnham CA, Clarridge JE, Qin X, Smith AL. 2013. Adhesin genes and serum resistance in Haemophilus influenzae type f isolates. J. Med. Microbiol. 62:514-524. http://dx.doi.org/10.1099/jmm.0.052175-0.
13. Rodriguez CA, Avadhanula V, Buscher A, Smith AL, St. Geme JW, III, Adderson EE. 2003. Prevalence and distribution of adhesins in invasive non-type b encapsulated Haemophilus influenzae. Infect. Immun. 71: 1635-1642. http://dx.doi.org/10.1128/IAI.71.4.1635-1642.2003.
14. Spahich NA, St. Geme JW, III. 2011. Structure and function of the Haemophilus influenzae autotransporters. Front. Cell. Infect. Microbiol. 1:5. http://dx.doi.org/10.3389/fcimb.2011.00005.
15. Hallström T, Riesbeck K. 2010. Haemophilus influenzae and the complement system. Trends Microbiol. 18:258-265. http://dx.doi.org/10.1016/j.tim.2010.03.007.
16. Winkelstein JA, Moxon ER. 1992. The role of complement in the host's defense against Haemophilus influenzae. J. Infect. Dis. 165(Suppl 1):S62-S65. http://dx.doi.org/10.1093/infdis/165-Supplement_1-S62.
17. Singh B, Blom AM, Unal C, Nilson B, Morgelin M, Riesbeck K. 2010. Vitronectin binds to the head region of Moraxella catarrhalis ubiquitous surface protein A2 and confers complement-inhibitory activity. Mol. Microbiol. 75:1426-1444. http://dx.doi.org/10.1111/j.1365-2958.2010.07066.x.
18. Singh B, Jalalvand F, Morgelin M, Zipfel P, Blom AM, Riesbeck K. 2011. Haemophilus influenzae protein E recognizes the C-terminal domain of vitronectin and modulates the membrane attack complex. Mol. Microbiol. 81:80-98. http://dx.doi.org/10.1111/j.1365-2958.2011.07678.x.
19. Voss S, Hallstrom T, Saleh M, Burchhardt G, Pribyl T, Singh B, Riesbeck K, Zipfel PF, Hammerschmidt S. 2013. The choline-binding protein PspC of Streptococcus pneumoniae interacts with the C-terminal heparin-binding domain of vitronectin. J. Biol. Chem. 288:15614-15627. http://dx.doi.org/10.1074/jbc.M112.443507.
20. Singh B, Yu-Ching Su, Riesbeck K. 2011. Vitronectin in host pathogen interactions and antimicrobial therapeutic applications. Cent. Eur. J. Biol. 6:973-980. http://dx.doi.org/10.2478/s11535-011-0077-x.
21. Singh B, Su YC, Riesbeck K. 2010. Vitronectin in bacterial pathogenesis: a host protein used in complement escape and cellular invasion. Mol. Microbiol. 78:545-560. http://dx.doi.org/10.1111/j.1365-2958.2010.07373.x.
22. Bergmann S, Lang A, Rohde M, Agarwal V, Rennemeier C, Grashoff C, Preissner KT, Hammerschmidt S. 2009. Integrin-linked kinase is required for vitronectin-mediated internalization of Streptococcus pneumoniae by host cells. J. Cell Sci. 122:256-267. http://dx.doi.org/10.1242/jcs.035600.
23. Leroy-Dudal J, Gagniere H, Cossard E, Carreiras F, Di Martino P. 2004. Role of αvβ5 integrins and vitronectin in Pseudomonas aeruginosa PAK interaction with A549 respiratory cells. Microbes Infect. 6:875-881. http://dx.doi.org/10.1016/j.micinf.2004.05.004.
24. Su YC, Jalalvand F, Morgelin M, Blom AM, Singh B, Riesbeck K. 2013. Haemophilus influenzae acquires vitronectin via the ubiquitous protein F to subvert host innate immunity. Mol. Microbiol. 87:1245-1266. http://dx.doi.org/10.1111/mmi.12164.
25. Hallström T, Trajkovska E, Forsgren A, Riesbeck K. 2006. Haemophilus influenzae surface fibrils contribute to serum resistance by interacting with vitronectin. J. Immunol. 177:430-436. (Erratum, 190:4431, 2013). http://dx.doi.org/10.4049/jimmunol.1390012.
26. Roth J. 1996. The silver anniversary of gold: 25 years of the colloidal gold marker system for immunocytochemistry and histochemistry. Histochem. Cell Biol. 106:1-8. http://dx.doi.org/10.1007/BF02473197.
27. Carlemalm E. 1990. Lowicryl resins in microbiology. J. Struct. Biol. 104: 189-191. http://dx.doi.org/10.1016/1047-8477(90)90075-N.
28. Bengtson SH, Eddleston J, Morgelin M, Zuraw BL, Herwald H. 2008. Regulation of kinin B2 receptors by bradykinin in human lung cells. Biol. Chem. 389:1435-1440. http://dx.doi.org/10.1515/BC.2008.159.
29. Sa E Cunha C, Griffiths NJ, Virji M. 2010. Neisseria meningitidis Opc invasin binds to the sulphated tyrosines of activated vitronectin to attach to and invade human brain endothelial cells. PLoS Pathog. 6:e1000911. http://dx.doi.org/10.1371/journal.ppat.1000911.
30. Radin JN, Grass SA, Meng G, Cotter SE, Waksman G, St. Geme JW, III. 2009. Structural basis for the differential binding affinities of the HsfBD1 and HsfBD2 domains in the Haemophilus influenzae Hsf adhesin. J. Bacteriol. 191:5068-5075. http://dx.doi.org/10.1128/JB.00395-09.
31. Zipfel PF. 2009. Complement and immune defense: from innate immunity to human diseases. Immunol. Lett. 126:1-7. http://dx.doi.org/10.1016/j.imlet.2009.07.005.